Association of benign prostatic hyperplasia (BPH) volume and prostate cancer: consecutive data from an academic institution in respect to the current scientific view
- PMID: 28314906
- DOI: 10.1007/s00345-017-2031-7
Association of benign prostatic hyperplasia (BPH) volume and prostate cancer: consecutive data from an academic institution in respect to the current scientific view
Similar articles
-
Is there a relationship between benign prostatic hyperplasia and prostatic cancer?Eur Urol. 1991;20 Suppl 1:31-5. doi: 10.1159/000471743. Eur Urol. 1991. PMID: 1722159 Review.
-
Dutasteride improves outcomes of benign prostatic hyperplasia when evaluated for prostate cancer risk reduction: secondary analysis of the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial.Urology. 2011 Sep;78(3):641-6. doi: 10.1016/j.urology.2011.03.063. Epub 2011 Jul 20. Urology. 2011. PMID: 21764428 Clinical Trial.
-
Association of elevated interleukin-17 and angiopoietin-2 with prostate size in benign prostatic hyperplasia.Aging Male. 2017 Jun;20(2):115-118. doi: 10.1080/13685538.2017.1284778. Epub 2017 Feb 21. Aging Male. 2017. PMID: 28590830
-
Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases.Urology. 2004 Oct;64(4):707-11. doi: 10.1016/j.urology.2004.04.046. Urology. 2004. PMID: 15491706
-
Benign prostatic hyperplasia and prostate cancer.Epidemiol Rev. 2001;23(1):152-8. doi: 10.1093/oxfordjournals.epirev.a000782. Epidemiol Rev. 2001. PMID: 11588841 Review. No abstract available.
Cited by
-
ESTAT3 Inhibitor AG-490 Inhibits the Growth of Prostate Cancer by miR-503-5p Both In Vivo and In Vitro.Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820948062. doi: 10.1177/1533033820948062. Technol Cancer Res Treat. 2020. PMID: 33063634 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical